Back to today’s briefing

Story perspectives

Drug Giants Urge Halt to Medicare Price Negotiations Amid FTC Revelations

1/15/2025

49 6

Summary

Story summary

Major drug companies are calling on the Trump administration to halt Medicare drug-price negotiations, which have already saved seniors a staggering $1.5 billion. At the same time, a new FTC report exposes how the top three pharmacy benefit managers are inflating specialty drug prices, burdening patients and healthcare systems with higher costs.

1 of 1

Story summary

Major drug companies are calling on the Trump administration to halt Medicare drug-price negotiations, which have already saved seniors a staggering $1.5 billion. At the same time, a new FTC report exposes how the top three pharmacy benefit managers are inflating specialty drug prices, burdening patients and healthcare systems with higher costs.